(917) 310-3371
Mechanism
Tirzepatide works through GIP and GLP-1 pathways, while semaglutide works through GLP-1 alone. That difference is part of why the clinical conversation often starts with comparison.
Tirzepatide activates both GIP and GLP-1 pathways, while semaglutide targets GLP-1 alone. Head-to-head obesity data and real-world comparisons generally show greater average weight loss with tirzepatide, but semaglutide can still be the better fit when coverage, supply, previous response, side-effect tolerance, or a patient’s broader treatment history points that way.
Many major insurance plans are accepted for eligible medical weight-loss visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Tirzepatide medication coverage is separate from visit coverage and often depends on the prescription benefit, prior authorization rules, employer exclusions, and current pharmacy fulfillment.
Tirzepatide activates both GIP and GLP-1 pathways, while semaglutide targets GLP-1 alone. Head-to-head obesity data and real-world comparisons generally show greater average weight loss with tirzepatide, but semaglutide can still be the better fit when coverage, supply, previous response, side-effect tolerance, or a patient’s broader treatment history points that way.
Tirzepatide works through GIP and GLP-1 pathways, while semaglutide works through GLP-1 alone. That difference is part of why the clinical conversation often starts with comparison.
Current head-to-head obesity data and real-world comparisons generally favor tirzepatide on average weight loss, but individual fit still depends on tolerance and access.
Semaglutide and tirzepatide can have very different coverage rules and pharmacy stability for the same patient, so the practical winner is not always the statistical winner.
Patients who are already doing well on semaglutide, have better coverage, or want the path with less change may not need to switch just because tirzepatide trends stronger on paper.
Nao Medical offers provider-guided tirzepatide evaluation for chronic weight management across NYC and Long Island, including candidacy review, insurance and self-pay planning, dose-escalation follow-up, and practical comparison against semaglutide when patients need to decide which GLP-1 path fits better.
Good tirzepatide care is not just a prescription. It usually means slow dose escalation, side-effect review, appetite and hydration check-ins, constipation or nausea management, weight and symptom tracking, and clear guidance on when to hold, continue, or escalate the dose.
Many major insurance plans are accepted for eligible medical weight-loss visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Tirzepatide medication coverage is separate from visit coverage and often depends on the prescription benefit, prior authorization rules, employer exclusions, and current pharmacy fulfillment.
These existing weight-loss pages are the fastest way to move from research into a real Nao Medical location and booking path.
Bronx
932 E 174th St, Bronx, NY 10460
A Bronx access point for provider-guided tirzepatide evaluation, medication follow-up, and practical weight-loss visits for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods.
View local weight-loss page Get directions
Queens
37-15 23rd Ave, Astoria, NY 11105
A Queens access point for provider-guided tirzepatide evaluation, medication follow-up, and practical weight-loss visits for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods.
View local weight-loss page Get directions
Bronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for provider-guided tirzepatide evaluation, medication follow-up, and practical weight-loss visits for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods.
View local weight-loss page Get directions
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
A Brooklyn access point for provider-guided tirzepatide evaluation, medication follow-up, and practical weight-loss visits for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods.
View local weight-loss page Get directions
Long Island
232 W Old Country Rd, Hicksville, NY 11801
A Long Island access point for provider-guided tirzepatide evaluation, medication follow-up, and practical weight-loss visits for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities.
View local weight-loss page Get directions
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
A Queens access point for provider-guided tirzepatide evaluation, medication follow-up, and practical weight-loss visits for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods.
View local weight-loss page Get directions
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
A Queens access point for provider-guided tirzepatide evaluation, medication follow-up, and practical weight-loss visits for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods.
View local weight-loss page Get directions
Queens
30-07 36th Ave, Astoria, NY 11106
A Queens access point for provider-guided tirzepatide evaluation, medication follow-up, and practical weight-loss visits for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods.
View local weight-loss page Get directions
Long Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for provider-guided tirzepatide evaluation, medication follow-up, and practical weight-loss visits for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities.
View local weight-loss page Get directions
Manhattan
259 1st Ave, New York, NY 10003
A Manhattan access point for provider-guided tirzepatide evaluation, medication follow-up, and practical weight-loss visits for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods.
View local weight-loss page Get directions
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn access point for provider-guided tirzepatide evaluation, medication follow-up, and practical weight-loss visits for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods.
View local weight-loss page Get directionsWhat patients say about Nao Medical
Verified Patient
The comparison page was much more practical than the usual drug-vs-drug blog post.
Verified Patient
Helpful that it covered coverage and follow-up instead of only the trial headline.
Verified Patient
This made the semaglutide vs tirzepatide decision less abstract.
Use the main tirzepatide hub for the full lane, or pick a location page if you already know the visit needs to happen close to home.
Open main tirzepatide hub